Stuart Chipkin to Biomarkers
This is a "connection" page, showing publications Stuart Chipkin has written about Biomarkers.
Connection Strength
0.125
-
Lazar HL, Joseph L, San Mateo C, Frame J, Cabral HJ, McDonnell M, Chipkin S. Expression of inducible nitric oxide synthase in conduits used in patients with diabetes mellitus undergoing coronary revascularization. J Card Surg. 2010 Jan-Feb; 25(1):120-6.
Score: 0.054
-
Chipkin SR. How to select and combine oral agents for patients with type 2 diabetes mellitus. Am J Med. 2005 May; 118 Suppl 5A:4S-13S.
Score: 0.040
-
Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg. 2011 Sep; 254(3):458-63; discussion 463-4.
Score: 0.015
-
Hyldahl RD, Xin L, Hubal MJ, Moeckel-Cole S, Chipkin S, Clarkson PM. Activation of nuclear factor-?B following muscle eccentric contractions in humans is localized primarily to skeletal muscle-residing pericytes. FASEB J. 2011 Sep; 25(9):2956-66.
Score: 0.015